Prophylaxis in congenital factor VII deficiency: Indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)

Haematologica

Volumn 98, Issue 4, 2013, Pages 538-544

  Napolitano, Mariasanta ^a   Giansily Blaizot, Muriel ^b   Dolce, Alberto ^c   Schved, Jean F ^b   Auerswald, Guenter ^d   Ingerslev, Jørgen ^e   Bjerre, Jens ^f   Altisent, Carmen ^g   Charoenkwan, Pimlak ^h   Michaels, Lisa ⁱ   Chuansumrit, Ampaiwan ^j   Di Minno, Giovanni ^k   Caliskan, Ümran ^l   Mariani, Guglielmo ^m  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

^d KLINIKUM BREMEN MITTE   (Germany)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f NOVO NORDISK A S   (Denmark)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h CHIANG MAI UNIVERSITY   (Thailand)

ⁱ Robert Wood Johnson University   (United States)

^j MAHIDOL UNIVERSITY   (Thailand)

^k UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^l SELCUK UNIVERSITY   (Turkey)

^m UNIVERSITY OF FERRARA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEMARTHROSIS; HUMAN; INFANT; MALE; MENORRHAGIA; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PROPHYLAXIS; PROSPECTIVE STUDY; SAFETY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FACTOR VII; FACTOR VII DEFICIENCY; FACTOR VIIA; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PLASMA; RECOMBINANT PROTEINS; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875640037     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.074039     Document Type: Article

References (41)

1. Mariani G, Bernardi F. Factor VII deficiency. Semin Thromb Hemost. 2009;35(4):400-6.
2. Mariani G, Dolce A. Congenital factor VII defiency. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Haemophilia. 2nd ed. Oxford: Wiley-Blackwell; 2010:341-7.
3. Borhany M, Pahore Z, Ul Qadr Z, Rehan M, Naz A, Khan A, et al. Bleeding disorders in the tribe: result of consanguineous in breeding. Orphanet J Rare Dis. 2010;5:23.
4. Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005;93(3):481-7.
5. Bernardi F, Dolce A, Pinotti M, Shapiro AD, Santagostino E, Peyvandi F, et al. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B. J Thromb Haemost. 2009;7(5):774-9.
6. Todd T, Perry DJ. A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies. Haemophilia. 2010;16(4):569-83.
7. Berrettini M, Mariani G, Schiavoni M, Rocino A, Di Paolantonio T, Longo G, Morfini M. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency. Haematologica. 2001;86(6):640-5.
8. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357 (6):535-44.
9. Manco-Johnson M. Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice. Haemophilia. 2007;13(Suppl 2):4-9.
10. Gringeri A, Lundin B, von MS, Mantovani L, Mannucci PM. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study). J Thromb Haemost. 2011;9(4):700-10.
11. Fischer K, van den Berg HM. Prophylaxis. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Hemophilia. 2nd ed. Oxford: Wiley-Blackwell; 2010:38-43.
12. Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII-a critical appraisal. Haemophilia. 2006;12(1): 19-27.
13. Chuansumrit A, Visanuyothin N, Puapunwattana S, Chaivisuth A, Rasmidat P, Charoenkwan P, Chiemchanya S. Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency. J Med Assoc Thai. 2002;85 (Suppl 4): S1059-64.
14. Cohen LJ, McWilliams NB, Neuberg R, Zinkham W, Bauer K, Gribble TJ, et al. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports. Am J Hematol. 1995;50(4):269-76.
15. Farah RA, Hamod D, Melick N, Giansily-Blaizot M, Sallah S. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency. J Thromb Haemost. 2007;5(2):433-4.
16. Halsey C, Singer JD, Manning R, Laffan M, Layton M. The use of prophylactic recombinant factor VII to prevent intracranial haemorrhage in an infant with severe factor VII deficiency. Br J Haematol. 2002;117 (Suppl 1):11-2.
17. Holve S, Stuart R, Recht M. Prophylaxis of recurrent epistaxis and menorrhagia using recombinant factor VIIa in severe congenital factor VII deficiency. Pediatr Res. 2001;49(4):203A.
18. Huth-Kühne A, Loges P, Zimmermann R. Regular prophylaxis with recombinant factor VIIa in a patient with severe congenital FVII deficiency. Haemostaseologie. 2008;28(Suppl 1):S55.
19. Jahromi BJ, Karimi M. Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency. Haemophilia. 2011;17(4): 713-5.
20. Karimi M, Shafieian R. Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency. Haemophilia. 2008;14 (4):851-2.
21. Karayalcin G, Hart D. Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency. Pediatr Res. 2002;51(4):259A-60A.
22. Kuperman AA, Livnat T, Braester A, Amar N, Kenet G. Rationale for tailored prophylaxis with recombinant FVIIa in severe congenital factor VII deficiency. J Thromb Haemost 2011;9(Suppl 2):695. Abstract 55513.
23. Recht M, Holve S, Stuart R, Hu D, Moul S. Prophylaxis of bleeding using recombinant factor VIIa in an infant with severe congenital factor VII deficiency. Pediatr Res. 2002;51(4):260A.
24. Salcioglu Z, Akcay A, Sen HS, Aydogan G, Akici F, Tugcu D, et al. Factor VII deficiency: a single-center experience. Clin Appl Thromb Haemost. 2012; 18(6):588-93.
25. Tokgoz H, Caliskan U, Lavigne-Lissalde G, Giansily-Blaizot M. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII. Haemophilia. 2012;18(1):e25-e27.
26. Kankirawatana S, Mahasandana C, Veerakul G, Seeloem J, Suwantol L, Tanphaichitr V, Suvatte V. Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency. Southeast Asian J Trop Med Public Health. 2000;31(4):795-800.
27. Mathijssen NC, Masereeuw R, Verbeek K, Lavergne JM, Costa JM, van Heerde WL, Nováková IR. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients. Br J Haematol. 2004;125(4):494-9.
28. Michaels LA, Philipp CS, Eisele J, Pappas H, Saidi P. Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII. Pediatr Blood Cancer. 2007;49(5):736-9.
29. Tcheng WY, Donkin J, Konzal S, Wong WY. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency. Haemophilia. 2004;10(3):295-8.
30. Ingerslev J, Christiansen K, Sorensen B. Inhibitor to factor VII in severe factor VII deficiency: detection and course of the inhibitory response. J Thromb Haemost. 2005;3(4):799-800.
31. Hoffman M, Colina CM, McDonald AG, Arepally GM, Pedersen L, Monroe DM. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost. 2007;5(7):1403-8.
32. Nayak RC, Sen P, Ghosh S, Gopalakrishnan R, Esmon CT, Pendurthi UR, Rao LV. Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications. Blood. 2009;114(9): 1974-86.
33. Sen P, Gopalakrishnan R, Kothari H, Keshava S, Clark CA, Esmon CT, et al. Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor I and mediates cell signaling and barrier protection. Blood. 2011;117(11): 3199-208.
34. Ragni MV, Lewis JH, Spero JA, Hasiba U. Factor VII deficiency. Am J Hematol. 1981;10(1):79-88.
35. Hennewig U, Eisert S, Wulff K, Herrmann FH, Schneider DT, Gobel U. Long-term FVII substitution in a preterm infant with severe gastrointestinal bleeding and FVII deficiency due to a homozygous donor splice mutation IVS4+1G-->A. Pediatr Hematol Oncol. 2006;23(2):129-33.
36. Giansily-Blaizot M, Aguilar-Martinez P, Briquel ME, d'Oiron R, De Maistre E, Epelbaum S, Schved JF. Two novel cases of cerebral haemorrhages at the neonatal period associated with inherited factor VII deficiency, one of them revealing a new nonsense mutation (Ser52Stop). Blood Coagul Fibrinolysis. 2003;14(2):217-20.
37. Mariani G, Napolitano M, Dolce A, Pérez Garrido R, Batorova A, Karimi M, et al. Replacement therapy for bleeding episodes in factor VII deficiency: a prospective evaluation. Thromb Haemost. 2013;109(2):238-47.
38. Pruthi RK, Rodriguez V, Allen C, Slaby JA, Schmidt KA, Plumhoff EA. Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G). Eur J Haematol. 2007;79(4):354-9.
39. Nicolaisen EM. Long-term follow-up with regard to potential immunogenicity: clinical experience with NovoSeven (recombinant factor VIIa). Haemostasis. 1996;26 (Suppl 1):98-101.
40. Mariani G, Herrmann FH, Schulman S, Batorova A, Wulff K, Etro D, et al. Thrombosis in inherited factor VII deficiency. J Thromb Haemost. 2003;1 (10):2153-8.
41. Mariani G, Dolce A, Batorova A, Auerswald G, Schved JF, Siragusa S, et al. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation-the surgical STER. Br J Haematol. 2011;152(3):340-6.